FierceBiotech ١٢ مارس ٢٠٢٦ Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
Agilent ٩ مارس ٢٠٢٦ Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip - Investing.com
BioPharma Dive ٦ مارس ٢٠٢٦ Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
Endpoints News ٦ مارس ٢٠٢٦ Pfizer gets obesity drug approval in China shortly after buying local rights
FierceBiotech ٤ مارس ٢٠٢٦ Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations
FierceBiotech ٢٥ فبراير ٢٠٢٦ After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
Endpoints News ٢٤ فبراير ٢٠٢٦ Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Endpoints News ٧ فبراير ٢٠٢٦ The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
FierceBiotech ٦ فبراير ٢٠٢٦ Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
BioPharma Dive ٤ فبراير ٢٠٢٦ Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
FierceBiotech ٤ فبراير ٢٠٢٦ Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
FierceBiotech ٣ فبراير ٢٠٢٦ Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges